MedTrace Logo

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

NCT03060889 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2017-02-23

No results posted yet for this study

Summary

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Conditions

  • Placenta Previa

Interventions

DRUG

Tranexamic acid

10 mg/kg body weight will be given with induction of anesthesia by intravenous infusion

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-11-30
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060889 on ClinicalTrials.gov